Geetha Puthenveetil, MD specializes in all aspects of hematology with emphasis in hemoglobinopathies, including Beta Thalassemia and Sickle Cell disease. Dr. Puthenveetil is board certified in pediatrics and in pediatric hematology-oncology. She received her medical degree from St. John's Medical College in Karnataka, India. She completed pediatric residency training at St. John's Medical College Hospital and at New York Medical College in Valhalla, New York. She completed a pediatric hematology-oncology fellowship at Children's Hospital Los Angeles/University of Southern California.
Dr. Putheveetil is part of the national sickle cell network. She is currently part of an international study looking at standards of care with sickle cell patients. Helping to facilitate this research, Dr. Putheveetil established a comprehensive red cell clinic at CHOC to treat patients with red cell disorders—including sickle cell disease, thalassemia, aplastic anemia, and Diamond-Blackfan Anemia. The clinic is attended by a cardiologist, endocrinologist, and hematologist and provides comprehensive care for patients.
Inflammatory Polyps following successful HLA-matched cord blood transplantation in a patient with X-linked lymphoproliferative syndrome. Buchbinder D, Younes B, Sassoon A, Soni A, Hsieh L, Puthenveetil G, Stites J, Ness-Jorden T, Neudorf S, Nugent D. Pediatr Transplant 2011 July 8. (Epub ahead of print). PMID 21736679 [PubMed – as supplied by publisher]
Unrelated Hematopoietic Stem Cell Transplantation in a patient with Congenital Dyserythropoietic Anemia and Iron Overload. Buchbinder D, Nugent D, Vu D, Soni A, Stites J, Hsieh L, Puthenveetil G. Pediatr Transplant. 2010 Nov 26. (Epub ahead of print) PMID 21108711 [PubMed as supplied by publisher]
Effect of Immune Therapy on PNH Clone Size and Bone Marrow Cellularity. David Shyr MD, Geetha Puthenveetil MD, Children’s Hospital of Orange County. Abstract accepted for a poster presentation at the Annual meeting of the American Society of Pediatric Hematology/Oncology in April 2010
New Approach in treating pediatric Hemangiomas . Jill Stites FNP, Geetha Puthenveetil MD, Children’s Hospital of Orange County Abstract accepted for a poster presentation at the Annual meeting of the American Society of Pediatric Hematology/Oncology in April 2010
Deferasirox is a safe and effective iron chelator in thalassemia patients post bone marrow transplantation – Poster presentation – Ninth Cooley’s Anemia Symposium, 10/09
Below is information removed from this biography that the subject specifically requested be included:
“Successful Correction of the Human Beta Thalassemia Major Phenotype Using a Lentiviral Vector” for the journal, Blood, 2004
“Successful Correction of the Human Cooley’s Anemia (beta) – Thalassemia Major Phenotype Using a Lentiviral Vector Flanked by the Chicken Hypersensitive Site 4 Chromatin Insulator” for the Annals of the New York Academy of Sciences, 2005 Presented on deferasirox as a safe and effective iron chelator in thalassemia patients post bone marrow transplantation at the Ninth Colley’s Anemia Symposium.
In 2010 at the annual meeting for the American Society of Pediatric Hematology/Oncology, Dr. Petheveetil coauthored the poster presentations “New Approach in Treating Pediatric Hemangiomas” and “The Effect of Immune Therapy on PNH Cone Size and Bone Marrow Cellularity.”
“Unrelated Hematopoietic Stem Cell Transplantation in a Patient with Congenital Dyserythropoietic Aneia and Iron Overload” accepted for publication in Pediatric Transplantation, the official journal of the International Pediatric Transplant Association.
CHOC Children's Specialists
1201 W La Veta
Orange, CA 92868
phone: (714) 509-8459
fax: (714) 509-8771
map & directions
St Joseph Hospital
1100 W Stewart Dr
Orange, CA 92868
map & directions